Ordaos Bio Alternatives & Competitors
12 companies similar to Ordaos Bio — Ordaōs creates de novo mini-proteins to help drug hunters deliver life-saving tr...
Companies similar to Ordaos Bio
AsedaSciences®
Helping scientists develop safer chemicals
AQEMIA
Scale drug discovery with quantum-inspired physics and generative AI
FluoSphera
The only company with a suite of systemic and high-throughput in vitro drug discovery solu...
Creyon Bio
Delivering RNA breakthroughs. Redefining hope.
Rival Readout
Competing with Ordaos Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Metrion Biosciences
The specialist CRO for ion channel, cardiac safety and neuroscience electrophysiology
Ignota Labs
Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects a...
BDD
Redefining Early Stage Development
Gordion Bioscience
MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING
Twist Bioscience
Synthetic DNA for Health & Sustainability
Baseimmune
Pioneering the next generation of active immunotherapies for chronic diseases
Synthace
Helping scientists solve the world's most pressing problems with faster, more powerful exp...
Menten AI
Unlocking the potential of peptides macrocycles to create tomorrow's life-changing medicin...
About Ordaos Bio
Ordaos Bio is a pioneering entity in the Biotechnology and Life Sciences industries. Founded in 2019 and headquartered in the United States, this innovative company is making significant strides in drug design through its unique synthesis of human initiative and machine-driven processes. The company's slogan, "Ordaōs c...
Development of mini-proteins and single domain antibodies, Generative AI-driven drug design, Multitask meta-learning Design Engine for protein creation, Optimization of therapeutics using AI
Pharmaceutical companies, Biotech firms, Drug hunters, Researchers focusing on novel therapies, Healthcare professionals seeking AI-driven solutions
De Novo Protein Design, Mini-proteins, In Silico Drug Design, Machine-driven Drug Discovery, Pharmaceutical Innovation, Biotechnology Solutions, Custom Protein Development, Therapeutic Proteins, In Vitro Protein Testing, Drug Discovery Acceleration, Clinical Success Probability, Novel Therapies, Patient Health Improvement, Life-extension Treatments, Drug Safety And Efficacy
B2B, SaaS, Platform
Project Based, Licensing, Subscription
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Ordaos Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Ordaos Bio on 15 Jun 2026. The 12 companies listed here were last checked between 13 Nov 2025 and 5 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.